Quick Answer
RxSight, Inc. reported Gross Profit of $103.01 million for fiscal year 2025.
RxSight, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $103.01M | +4.1% |
| 2024 | $98.94M | +84.0% |
| 2023 | $53.77M | +152.1% |
| 2022 | $21.33M | +372.2% |
| 2021 | $4.52M | +164.9% |
| 2020 | $1.71M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $24.23M | -3.9% | -3.8% |
| June 30, 2025 | $25.19M | +3.9% | -11.1% |
| March 31, 2025 | $28.33M | +37.0% | +12.3% |
| September 30, 2024 | $25.22M | +83.7% | +4.0% |
| June 30, 2024 | $24.25M | +101.8% | +17.2% |
| March 31, 2024 | $20.68M | +99.5% | +50.6% |
| September 30, 2023 | $13.73M | +156.4% | +14.3% |
| June 30, 2023 | $12.02M | +150.9% | +15.9% |
- RxSight, Inc. showed an increase of +4.1% in Gross Profit compared to the prior fiscal year.
- Over the 2020–2025 period, RxSight, Inc.’s gross profit has grown by 5941.6% (from $1.71 million to $103.01 million).
- The most recent figure is from RxSight, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: